logo-loader
viewDeere & Company

Deere & Company shares wobble after fiscal 3Q earnings miss on revenue beat

Tariffs, higher material and transportation costs weigh on profits, but management is still optimistic about the overall farming outlook

A farmer working on his field with a tractor
Deere & Company CEO Samuel R Allen says replacement demand for large agricultural equipment is driving sales despite tensions over global trade

Shares of Deere & Company (NYSE:DE) tumbled in premarket trade Friday after the agricultural machinery company posted fiscal third quarter earnings that missed Wall Street estimates despite strong revenues.

The Moline, Illinois-based company posted earnings of US$2.59 per share on revenue of US$10.3bn. The consensus earnings estimate was US$2.77 per share on revenue of US$9.2bn. Revenue grew 32% on a year-over-year basis.

Deere stock fell 5.8% to US$129.48 before the opening bell.

Tariffs, higher material and transportation costs are likely to weigh on profits but management still remained pretty optimistic about the overall farming outlook.

"We continue to believe Deere is well-positioned to capitalize on growth in the world's agricultural and construction equipment markets," said Deere & Company CEO Samuel R Allen.

"Replacement demand for large agricultural equipment is driving sales even in the face of tensions over global trade and other geopolitical issues. We are heartened by our customers' enthusiastic response to the advanced features and technology found on our new products," he added.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

Quick facts: Deere & Company

Price: 160.59 USD

NYSE:DE
Market: NYSE
Market Cap: $50.54 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Polarean Imaging achieves positive phase III results in two...

Polarean Imaging PLC (LON:POLX) CEO Richard Hullihen tells Proactive its two phase III clinical trials have 'demonstrated handily' that its technology allows doctors and surgeons to visualize aspects of lung function that have gone undetected using traditional magnetic resonances imaging (MRI)...

1 hour, 16 minutes ago

2 min read